SCHEMBL1849236

SCHEMBL1849236

CN(C)c1ccc(C=C2C(=O)Nc3ccc([N+](=O)[O-])cc32)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.67
MAPT P10636 6/20 0.67
SNCA P37840 5/20 0.67
NOX4 Q9NPH5 1/20 0.66
PDGFRB P09619 4/20 0.62
MEN1 O00255 2/20 0.62
ALDH1A1 P00352 2/20 0.62
MAPK1 P28482 2/20 0.62
KMT2A Q03164 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
NPC1 O15118 1/20 0.62
GMNN O75496 1/20 0.62
LMNA P02545 1/20 0.62
HPGD P15428 1/20 0.62
MTOR P42345 1/20 0.62
RAB9A P51151 1/20 0.62
BLM P54132 1/20 0.62
PMP22 Q01453 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1849235 1.00 APP (0.67) APPMAPTSNCANOX4PDGFRB
SCHEMBL3752053 0.86 NOX4 (0.70) APPMAPTSNCANOX4PDGFRB
SCHEMBL31219496 0.84 GSK3B (0.74) APPMAPTSNCANOX4PDGFRB
SCHEMBL3757258 0.84 GSK3B (0.74) APPMAPTSNCANOX4PDGFRB
SCHEMBL3757263 0.84 GSK3B (0.74) APPMAPTSNCANOX4PDGFRB
SCHEMBL1851095 0.83 RET (0.67) APPMAPTSNCANOX4PDGFRB
SCHEMBL1851097 0.83 RET (0.67) APPMAPTSNCANOX4PDGFRB
SCHEMBL13080904 0.83 RET (0.67) APPMAPTSNCANOX4PDGFRB
SCHEMBL1848262 0.81 NOX4 (0.66) APPMAPTSNCANOX4PDGFRB
SCHEMBL1848264 0.81 NOX4 (0.66) APPMAPTSNCANOX4PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB APP 1/4885MAPT 9/4885SNCA 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.